Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Friday, August 26, 2016
Here's what happened to AIDS drug that spiked 5000% KSAT San Antonio-20 hours ago
Re-reading The Real Voice by Richard Harris, on drug pricing concerns giving rise to drug hearings that began in 1959 and ended with the .
Excerpt:
"Blair telephoned Dr. Till, and she hurried over to his office. "My God, just look at those profits!" he said, waving the report at her.
The book opens with the words of Woodrow Wilson:
"Things get very lonely in Washington sometimes. The real voice of the great people of America sometimes sounds faint and distant in that strange city"
On the outcome of the hearing(s):
In separate views, Sen. Alexander Wiley (R Wis.) said the majority report did not find any violation of the antitrust laws but was worthwhile because it made the drug industry reevaluate its public responsibility. He said the investigation had enabled Congress to review the laws protecting the industry to see if they fostered the public interests.
1 comment:
Re-reading The Real Voice by Richard Harris, on drug pricing concerns giving rise to drug hearings that began in 1959 and ended with the .
Excerpt:
"Blair telephoned Dr. Till, and she hurried over to his office. "My God, just look at those profits!" he said, waving the report at her.
The book opens with the words of Woodrow Wilson:
"Things get very lonely in Washington sometimes. The real voice of the great people of America sometimes sounds faint and distant in that strange city"
On the outcome of the hearing(s):
In separate views, Sen. Alexander Wiley (R Wis.) said the majority report did not find any violation of the antitrust laws but was worthwhile because it made the drug industry reevaluate its public responsibility. He said the investigation had enabled Congress to review the laws protecting the industry to see if they fostered the public interests.
See excerpts of the committee report, here:
http://www.fda.gov/ohrms/dockets/dailys/04/apr04/042004/03p-0275-ref0001-079-Tab-32-vol5.pdf
Post a Comment